openPR Logo
Press release

Neuroendocrine Tumours Therapeutics Market | Global Industry Report 2019 - 2025

02-22-2019 10:13 AM CET | Health & Medicine

Press release from: Precision Business Insights

Neuroendocrine Tumours Therapeutics Market

Neuroendocrine Tumours Therapeutics Market

Neuroendocrine Tumours Therapeutics Market: Market Share, Size, Targeted Market And More

Neuroendocrine tumours (NET) are the abnormal growths which begin in neuroendocrine cells. Neuroendocrine which are similar to the nerve cells and hormones producing cells. Neuroendocrine tumours are rare and can occur anywhere in the body such as small intestine, lungs, rectum, appendix, and pancreas. Neuroendocrine tumours can be noncancerous (benign) or cancerous (malignant). NETs will arises from several neuroendocrine cells whose normal functions are to serve at neuroendocrine interface. Neuroendocrine cells will present throughout the body where hormones are produced but not only in the endocrine glands.

Request Sample Report:
https://precisionbusinessinsights.com/request-sample?product_id=15981

Neuroendocrine tumours therapeutics market expected to grow owing to increase in initiatives taken by various international organizations like American Association for Cancer Research (AACR) and World Health Organization to treat neuroendocrine tumours are expected to drive the growth of the neuroendocrine tumours treatment market. AACR provided $250,000 fund for the prevention of neuro endocrine tumours. Rise in health care expenditure, increase in prevalence rate of neuroendocrine tumours in developing regions is anticipated to drive global neuroendocrine tumours market. Though the market is expected to witness healthy growth, lack of skilled healthcare professional and lower adoption of advanced treatment technologies in the developing economies are key restraints for neuroendocrine tumours treatment market.
The global neuroendocrine tumours therapeutics market is categorized as below-

1. Drug class
• Somatostatin Analogues
o Octreotide
o Lanreotide
o Pasireotide
• Chemotherapeutics
o Fluorouracil (5-FU)
o Doxorubicin (Adriamycin) or liposomal doxorubicin (Doxil)
o Streptozocin
o Temozolomide (Temodar)
o Capecitabine (Xeloda)
o Dacarbazine (DTIC)
o Oxaliplatin (Eloxatin)
• Targeted Therapeutics
o Sunitinib
o Everolimus
• Others
2. Indication
• Lung NET
• Others NET
• Gastrointestinal NET
• Pancreatic NET
3. End-users
Hospital, retail pharmacies and others.
And lastly, on the basis of the geographical regions, the global neuroendocrine tumours therapeutics market is divided into five key regions- North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa. North America is dominant market for product launch and research and development activities, entrenched infrastructure and favorable reimbursement scenario are the major factors accountable for the strengthening of North America’s neuroendocrine tumours therapeutics market. Europe is the second largest market for neuroendocrine tumours therapeutics, followed by Asia-Pacific. Increased cases of neuroendocrine cancer in Asia-Pacific along with the refining economic scenario is expected to play an important role in driving the neuroendocrine (NET) market growth in this region. Some of the key players operating in the global neuroendocrine tumours therapeutics market include Pfizer Inc., (U.S), Eli Lilly & Company (U.S.), Novartis AG (Switzerland), F. Hoffmann-La Roche Ltd.(Switzerland), Ipsen (France), Amgen, Inc. (U.S.), Teva Pharmaceuticals, Ltd. (Israel), and Bristol-Myers Squibb (U.S.). In 2016, Novartis received the USFDA approval for its Afinitor® (Everolimus) tablets for the treatment of adult patients with progressive, well-differentiated, non-functional neuroendocrine tumours of gastrointestinal or lung origin.
The neuroendocrine tumor treatment market is expected to gain steady traction in the foreseeable future as there are many novel drugs are in pipeline. Increase in NET incidence and prevalence globally. Moreover, rise in survival rate of neuroendocrine tumours by treating with various medications are expected to have a positive impact on neuroendocrine tumours treatment market. According to the study published in the JAMA Oncology Journal (2017), the survival rate for all neuroendocrine tumor treatment have improved, especially for distant-stage gastrointestinal neuroendocrine tumour treatment and pancreatic neuroendocrine tumour treatment.

For More Information :https://precisionbusinessinsights.com/market-reports/global-neuroendocrine-tumours-therapeutics-market/

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuroendocrine Tumours Therapeutics Market | Global Industry Report 2019 - 2025 here

News-ID: 1609587 • Views: 213

More Releases from Precision Business Insights

Clinical Trials Market Share, Trends, Competitor Analysis and Forecast to 2019-2 …
Analyst Speak: “The Global Clinical Trials Market is expected to reach US$ 69.1 Bn by 2025 due to growing occurrences of life threatening diseases and technological advancements in the field of drug discovery” The global clinical trials market is expected to reach US$ 69.1 Bn by 2025. Clinical trials are experiments or observations done in clinical research to generate data on safety and efficacy. Clinical trials are done on vaccines, drugs,
Diabetes Care Devices Market is Expected to Reach US$ 24,368.4 Mn by 2025
Analyst Speak: “The Diabetes Care Devices Market is increasing at significant CAGR over the forecast period 2019-2025 and expected to reach US$ 24,368.4 Mn by 2025, due to rise in prevalence of diabetes in various countries around the world”. Precision Business Insights (PBI) in its report titled “Diabetes Care Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period
Carbon Fiber Prepreg Market Opportunities, Size, Share, Key Players, and Regiona …
The Global Carbon Fiber Prepreg Market poised to reach US$ XX Mn by 2025 with a significant CAGR over seven years forecast period 2019-2025 owing to the increasing demand from various industries. Precision Business Insights (PBI) in its report titled “Global Carbon Fiber Prepreg Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025.
Global Insulation Coatings Market Growth, Trends, Analysis, Segmentation, Foreca …
Precision Business Insights (PBI) in its report titled “Global Insulation Coating Material Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period from 2019 to 2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period. Global Insulation Coating Material Market

All 5 Releases


More Releases for Neuroendocrine

Neuroendocrine Carcinoma Market Analysis & Key Trends 2020
A neuroendocrine tumor is a kind of tumor that begins in the hormone producing cells of the neuroendocrine system that is made up of the endocrine system and nervous system. Hormones producing neuroendocrine cells have a structure similar to neurons and produce hormones like endocrine cells. These cells are found throughout the body in organs such as intestines, kidneys, lungs and stomach and perform functions such as controlling the speed
Will Neuroendocrine Carcinoma Market Perceive Robust Expansion by 2027?
Recently, Future Market Insights has presented value analysis and insights on the various disease types, treatment types and end users associated with the neuroendocrine carcinoma market across key regions in the globe. It has also included an in-depth analysis on the various key players participating in the global neuroendocrine carcinoma market along with key developments taking place during the 2017-2027 timeline. Future Market Insights, in its recent publication titled “Neuroendocrine
Neuroendocrine Carcinoma-Market Insights, Epidemiology and Market Forecast-2025
"The Report Neuroendocrine Carcinoma-Market Insights, Epidemiology and Market Forecast-2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​DelveInsights Neuroendocrine Carcinoma-Market Insights, Epidemiology and Market Forecast-Market Insights, Epidemiology and Market Forecast-2025 report provides an overview of the disease and in depth research related to Neuroendocrine Carcinoma-Market Insights, Epidemiology and Market Forecast for the 7MM (United States, Germany, France, Italy, Spain and UK) for
Neuroendocrine Tumors Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors - Pipeline Review, H1 2017, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape. Neuroendocrine tumor begins in the hormone-producing cells of the body's neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symptom includes hyperglycemia, diarrhea, loss of appetite/weight loss, thickening or lump in any part
Neuroendocrine Tumors Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors - Pipeline Review, H1 2017, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape. Neuroendocrine tumor begins in the hormone-producing cells of the body's neuroendocrine system, which is made up of cells that are a cross between traditional endocrine cells (or hormone-producing cells) and nerve cells. Symptom includes hyperglycemia, diarrhea, loss of appetite/weight loss, thickening or lump in any part
Global Neuroendocrine Tumor Treatment Market
The Global Neuroendocrine Tumor Treatment Market was valued at US$ 1,197.3 million in 2016 and is projected to expand at a CAGR of 10.5% during the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Better diagnostic techniques and products in pipeline are expected to be major factors driving growth of the global neuroendocrine tumor treatment market over the foreseeable future. Neuroendocrine Tumor (NET) are diagnosed